Six years ago, the news and communications team I led at the time was eager to show off its storytelling skills on behalf of Indiana University and, more importantly, to spotlight the work being done at IU to advance the top priority of the university’s newly adopted Bicentennial Strategic Plan: ensuring student success. Our creative… Read more »
Technology Commercialization
Giving thanks for a collective innovation culture
Heading into Thanksgiving week, Indiana University is seeing a cornucopia of major developments on the innovation front. Here’s a sampling of several recent advancements, which reflect how IU and its partners are furthering a collective innovation culture across Indiana. Furthering the IU-Crane connection. Earlier this week, at a signing event that included IU President Pamela… Read more »
IU students dominate recent 5G ‘hackathon’ competition
Talk about being “dialed in.” Students from Indiana University’s School of Informatics and Computing at IUPUI swept up several of the biggest prizes at the recently held AT&T 5G Sports Hackathon, the fifth tech competition that AT&T has hosted in central Indiana in the last six years. This year’s event, which was held at Butler… Read more »
Accelerating Indiana’s growth in AI, automation and STEM
If Indiana is like an IndyCar — racing against other states to transform big ideas into thriving businesses, attract new investment and accelerate growth in transformational industries such as artificial intelligence and automation — its flagship public university might be seen as a highly trained pit crew, engaging its vast educational resources and experience to… Read more »
Connecting capital to ideas and collaborating to ignite Indiana’s entrepreneurial ecosystem
For nearly two decades, Biocrossroads has established itself as a leader in helping to build Indiana’s life sciences sector and a major source of venture capital for Indiana-based life sciences startups. Biocrossroads has also been one of Indiana University’s most effective partners in helping to move laboratory discoveries into the marketplace and catalyzing a robust… Read more »
IU Ventures’ investment helps fuel continued growth of Indiana-based life sciences startup and newly named ‘Most Fundable’ company
The first-ever company to receive a double investment through IU Ventures’ startup support ecosystem, diagnostic cancer testing startup Amplified Sciences, just received some resounding support by way of one of the nation’s most rigorous startup competitions. Amplifed Sciences has landed on Pepperdine Graziadio Business School’s fourth-annual Most Fundable Companies List, which was announced during a… Read more »
IU ICO reports on 2019-20 fiscal year milestones
The 2019-20 fiscal year was a strong one for the Indiana University Innovation and Commercialization Office, said Simran Trana, IU associate vice president of innovation and commercialization. “This was an unusual year, and not only because of the impact of the novel coronavirus,” Trana said. “IU researchers quickly pivoted their work to create new methods… Read more »
These 64 IU researchers were named on issued patents in 2019-20
The Indiana University Innovation and Commercialization Office again reported a strong year in technology transfer activity. It received 157 patents from the U.S. Patent and Trademark Office and foreign patent organizations during the 2019-20 fiscal year. Sixty-four current IU researchers were named on the patents. They are: IU Bloomington Andrew Alexander Lane Baker Yves Brun… Read more »
Another example of IU expertise at innovation and commercialization
By Samantha Ginther, senior associate, IU Ventures Everyone at the Indiana University Innovation and Commercialization Office and IU Ventures congratulates drug discovery company MBX Biosciences for recently completing a $34.6 million Series A round of funding. This is the latest entrepreneurial good news for Indiana University researcher and Distinguished Professor Richard DiMarchi, IUPUI alumnus Kent… Read more »
Q&A with Nancy T. Chang, Ph.D., plenary speaker for the fifth annual Innovation and Commercialization Conference
Nancy T. Chang, Ph.D., founded Tanox, a biopharmaceutical company, in 1986 while on faculty at the Baylor College of Medicine. The company developed Xolair, an anti-inflammatory asthma treatment, that the U.S. Food and Drug Administration approved for use in 2003. Tanox was acquired by Genentech in 2007 for $919 million. Chang will speak during the… Read more »